Results 161 to 170 of about 14,427,656 (303)
Peptides that inhibit the association of the surface and core antigens of hepatitis B virus
This invention relates to isolation of high affinity binding phages carrying the fusion peptides which bind specifically to hepatitis B core antigen. A synthetic peptide derived from of the fusion peptides inhibits the association of hepatitis B surface ...
Seow, Heng Fong +3 more
core
Periodontitis and metabolic dysfunction‐associated steatotic liver disease
Abstract Objective Periodontitis is a chronic inflammatory disease with systemic effects that extend beyond the oral cavity and contribute to systemic immune and metabolic dysregulation. Chronic liver diseases, particularly metabolic dysfunction‐associated steatotic liver disease (MASLD) and its progressive phenotypes, have emerged as major global ...
Rafael Scaf de Molon +6 more
wiley +1 more source
Hepatitis B virus core immunoglobulin M: false positive more common than true. [PDF]
Landry ML, Bernard PE.
europepmc +1 more source
Invalid Nucleic Acid Test Results May Limit Deceased Donor Organ Utilization
Rare instances occur in which discriminatory NAT results cannot be resolved in deceased organ donor cases. When these events occur the impact on organ donation can be substantial. ABSTRACT Background Nucleic acid testing (NAT) is essential for detecting transmissible viral infections in deceased organ donors and guiding safe organ allocation.
Sara Dionne +5 more
wiley +1 more source
Core protein mutations are key determinants of hepatitis B virus replication during the hepatitis B e antigen-negative stage. [PDF]
Flichman D +4 more
europepmc +1 more source
Hepatitis B : are you at risk? [French]
Hepatitis B : are you at risk? [French]These sheets have the English translation on the back.cdc/gov/knowhepatitisBhepbatrisk-africa_fr ...
core
Among 135 cases of post‐liver transplant HHV8 disease (4 from NSW), presentations varied, and mortality was high (44%). Donor screening was rare, and donor‐derived infection was suspected in 33%. Survival improved with mTORi, reduced immunosuppression, chemotherapy, and, for non‐KS disease, donor screening. ABSTRACT Background Human herpesvirus 8 (HHV8)
Karen M. J. Waller +12 more
wiley +1 more source
Decoding HBV-specific adaptive immunity: from natural clearance to cure. [PDF]
Thimme R +3 more
europepmc +1 more source
Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps
ABSTRACT Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through immunization. Despite this, HBV remains a leading cause of chronic liver disease globally, affecting over 250 million people.
Oscar A. Fernandez‐Garcia +3 more
wiley +1 more source

